| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.6609 | 
      | Human Intestinal Absorption | HIA- | 0.8407 | 
      | Caco-2 Permeability | Caco2- | 0.8957 | 
      | P-glycoprotein Substrate | Non-substrate | 0.5805 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8575 | 
                                                     | Non-inhibitor | 0.9425 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8490 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7211 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8745 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8540 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6605 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9472 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9556 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9386 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9134 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9774 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9619 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9692 | 
                                                                    | Non-inhibitor | 0.8684 | 
      | AMES Toxicity | Non AMES toxic | 0.9421 | 
      | Carcinogens | Non-carcinogens | 0.9569 | 
      | Fish Toxicity | Low FHMT | 0.7646 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.5575 | 
      | Honey Bee Toxicity | High HBT | 0.7253 | 
      | Biodegradation | Not ready biodegradable | 0.6719 | 
      | Acute Oral Toxicity | IV | 0.5349 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6723 |